Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality Therapy

IF 4.3 3区 材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC
Ethan P. Damron , Jordan McDonald , Michael K. Rooney , Prajnan Das , Ethan B. Ludmir , Bruce D. Minsky , Craig Messick , George J. Chang , Van K. Morris , Emma B. Holliday
{"title":"Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality Therapy","authors":"Ethan P. Damron ,&nbsp;Jordan McDonald ,&nbsp;Michael K. Rooney ,&nbsp;Prajnan Das ,&nbsp;Ethan B. Ludmir ,&nbsp;Bruce D. Minsky ,&nbsp;Craig Messick ,&nbsp;George J. Chang ,&nbsp;Van K. Morris ,&nbsp;Emma B. Holliday","doi":"10.1016/j.clcc.2023.12.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The standard treatment for recurrent or persistent anal squamous cell carcinoma is surgical salvage, but disease control and survival are suboptimal.</p></div><div><h3>Patients/Methods</h3><p>Patients treated for recurrent or persistent anal squamous cell carcinoma at our institution from 2002 to 2022 were included. Patients were classified by type of salvage treatment received: surgery alone vs. reirradiation followed by surgery and by whether they received intraoperative radiation at the time of surgery. Clinical and pathologic variables were collected and assessed for association with risk of second local recurrence and death from any cause.</p></div><div><h3>Results</h3><p>Sixty four patients were included; 55(85.9%) were treated with surgery alone and 9 (14.1%) were treated with reirradiation followed by surgery. Median (IQR) follow up from the time of salvage treatment was 40.0 (20.3-68.0) months. The 3-year cumulative incidence of second local recurrence (95% CI) after salvage surgery was 36% (24%-48%); 39% (26%-52%) for patients treated with surgery alone and 15% (0.46%-51%) for patients treated with reirradiation followed by surgery. Factors associated with increased second local recurrence after salvage surgery included a locoregional recurrence, lymphovascular space invasion and positive surgical margins. The 3-year overall survival (95% CI) after salvage surgery was 70% (59%-83%); 68% (7%-56%) after surgery alone and 89% (10.5%-70.6%) after reirradiation followed by surgery. Factors associated with worse overall survival included male sex, a larger recurrent tumor and positive surgical margins.</p></div><div><h3>Conclusions</h3><p>Approximately 60% of patients achieved pelvic control after salvage therapy for recurrent or persistent anal squamous cell carcinoma. Although receipt of reirradiation and intraoperative radiation were not associated with improved second local recurrence or overall survival in our cohort, patients with positive surgical margins and lymphovascular space invasion on surgical pathology had higher rates of pelvic recurrence after salvage surgery and may benefit from escalated salvage therapy.</p></div>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S153300282300124X","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The standard treatment for recurrent or persistent anal squamous cell carcinoma is surgical salvage, but disease control and survival are suboptimal.

Patients/Methods

Patients treated for recurrent or persistent anal squamous cell carcinoma at our institution from 2002 to 2022 were included. Patients were classified by type of salvage treatment received: surgery alone vs. reirradiation followed by surgery and by whether they received intraoperative radiation at the time of surgery. Clinical and pathologic variables were collected and assessed for association with risk of second local recurrence and death from any cause.

Results

Sixty four patients were included; 55(85.9%) were treated with surgery alone and 9 (14.1%) were treated with reirradiation followed by surgery. Median (IQR) follow up from the time of salvage treatment was 40.0 (20.3-68.0) months. The 3-year cumulative incidence of second local recurrence (95% CI) after salvage surgery was 36% (24%-48%); 39% (26%-52%) for patients treated with surgery alone and 15% (0.46%-51%) for patients treated with reirradiation followed by surgery. Factors associated with increased second local recurrence after salvage surgery included a locoregional recurrence, lymphovascular space invasion and positive surgical margins. The 3-year overall survival (95% CI) after salvage surgery was 70% (59%-83%); 68% (7%-56%) after surgery alone and 89% (10.5%-70.6%) after reirradiation followed by surgery. Factors associated with worse overall survival included male sex, a larger recurrent tumor and positive surgical margins.

Conclusions

Approximately 60% of patients achieved pelvic control after salvage therapy for recurrent or persistent anal squamous cell carcinoma. Although receipt of reirradiation and intraoperative radiation were not associated with improved second local recurrence or overall survival in our cohort, patients with positive surgical margins and lymphovascular space invasion on surgical pathology had higher rates of pelvic recurrence after salvage surgery and may benefit from escalated salvage therapy.

复发性或顽固性肛门鳞状细胞癌的挽救治疗:多模式疗法的作用
背景复发性或顽固性肛门鳞状细胞癌的标准治疗方法是手术抢救,但疾病控制率和生存率并不理想。患者/方法纳入了2002年至2022年在本院接受治疗的复发性或顽固性肛门鳞状细胞癌患者。根据患者接受的挽救治疗类型进行分类:单纯手术与手术后再放疗,以及手术时是否接受术中放疗。研究人员收集了临床和病理变量,并评估了这些变量与第二次局部复发和任何原因导致的死亡风险之间的关系。结果共纳入64例患者,其中55例(85.9%)接受了单纯手术治疗,9例(14.1%)在手术后接受了再照射治疗。从挽救治疗开始的中位数[IQR]随访时间为40.0 [20.3-68.0] 个月。抢救性手术后再次局部复发的3年累积发生率(95% CI)为36%(24-48%);单纯手术治疗患者的发生率为39%(26-52%),再次照射后手术治疗患者的发生率为15%(0.46-51%)。与挽救手术后第二次局部复发增加相关的因素包括局部复发、淋巴管间隙侵犯和手术切缘阳性。抢救性手术后的3年总生存率(95% CI)为70%(59%-83%);单纯手术后为68%(7%-56%),再照射后再手术后为89%(10.5%-70.6%)。总生存率较低的相关因素包括男性、复发肿瘤较大和手术切缘阳性。结论约有60%的复发性或顽固性肛门鳞状细胞癌患者在接受挽救治疗后达到盆腔控制。虽然在我们的队列中,接受再次放疗和术中放疗与第二次局部复发或总生存率的改善无关,但手术病理检查发现手术边缘阳性和淋巴管间隙受侵的患者在挽救手术后盆腔复发率较高,可能会从升级的挽救治疗中获益.MicroAbstract复发性或顽固性肛门癌的标准治疗方法是手术挽救,但控制率和生存率并不理想。我们的目的是评估单纯挽救手术与多学科挽救治疗(包括再照射和/或术中照射)的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
4.30%
发文量
567
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信